Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.38%
#2 Victoria VR Victoria VR +9.12%
#3 Movement Movement +8.40%
#4 DMT-NAT DMT-NAT +6.25%
#5 Palladium Network Palladium Network +4.63%
#6 Pons Pons +4.23%
#7 GRVT Token GRVT Token +3.85%
#8 Cryptopia Cryptopia +3.74%
#9 MarsCoin MarsCoin +3.69%
#10 COTI COTI +3.65%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Kaleido Biosciences, Inc. Kaleido Biosciences, Inc.

Kaleido Biosciences, Inc.

KLDO
Rang in Aktien #42677
Kaleido Biosciences, Inc. is a clinical-stage healthcare firm dedicated to... Kaleido Biosciences, Inc. is a clinical-stage healthcare firm dedicated to pioneering microbiome metabolic therapies. Its pipeline includes specific drug candidates such as KB195 for urea cycle disorders, KB295 targeting ulcerative colitis, KB174 aimed at hepatic encephalopathy, and KB109 for COVID-19. The company is also advancing programs in other significant therapeutic areas, including multi-drug resistant infections, chronic kidney disease, atherosclerotic cardiovascular disease, cardio-metabolic syndrome, immuno-oncology, and various inflammatory bowel conditions. Kaleido maintains strategic collaborations with Institute Gustave Roussy, Washington University, and Janssen. Established in 2015, its headquarters are situated in Lexington, Massachusetts.
Aktienkurs
$0.00001
Zuletzt synchronisiert: 2026-07-30
Marktkapitalisierung
$426.00
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
-90.00%
Land
US
Handel Kaleido Biosciences, Inc. (KLDO)

Kategorie

Healthcare
Kursverlauf für Kaleido Biosciences, Inc. (KLDO)
Höchster Schlusskurs: $0.00 am 2026-07-01

Niedrigster Schlusskurs: $14.23 am 2019-02-01
Kursverlauf der Aktie von Kaleido Biosciences, Inc. von 2019 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 0.00%
2025 304.60%
2024 7.34%
2023 -92.98%
2022 -99.97%
2021 -65.59%
2020 50.15%
2019 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.87 33.33%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $873.57 35.10%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.38 7.69%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $263.09 18.09%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.08K -6.44%
KR